It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

Skip Navigation

Science & innovation

Baxter’s diverse scientific expertise and world-class capabilities in key technical areas are critical components in advancing patient care globally.

Baxter Ventures: Investing in Innovation

Baxter Ventures identifies companies with promising technologies, products and/or therapies, and provides them with the capital and expertise needed to drive successful innovation. Baxter Ventures was created in 2011 by Baxter International Inc., which has an 80-year legacy of supporting healthcare innovation and saving and sustaining lives worldwide.

Investment Focus

Baxter Ventures invests in companies with innovative technologies, products and therapies that have the ability to improve patient care globally and maximize value for investors and entrepreneurs. Our focus includes therapeutic areas complementary to those of our medical products business, as well as cutting-edge technologies and therapies outside of our current product portfolio that have sustainable long-term growth potential. Areas of interest include:

  • IV Solutions and Premixed Drugs
  • IV Infusion Systems and Administration Sets
  • Parenteral Nutrition
  • Pharmacy Automation, Software & Services
  • Surgical Care, including anesthesia and biosurgical products 
  • Renal Therapies, including continuous renal replacement, hemodialysis and peritoneal dialysis

Submit Your Proposal

Contact Us

For general questions and information, please contact the Center for One Baxter.

United States and Canada
Phone: 800-422-9837 (800-4Baxter)
Fax: 800-568-5020

Direct Dial: +1-224-948-1812
Fax: +1-224-948-3640
Business hours: 8am-5pm CT
E-mail

a wall